Open access
Open access
Powered by Google Translator Translator

Gynecology & Obstetrics (all articles)

Epidural-related maternal fever: incidence, pathophysiology, outcomes, and management

24 Mar, 2023 | 13:07h | UTC

Epidural-related maternal fever: incidence, pathophysiology, outcomes, and management – American Journal of Obstetrics & Gynecology (free for a limited period)

 

Commentary on Twitter

 


Study shows there is little evidence of heightened pregnancy risks for IVF-conceived parents

24 Mar, 2023 | 12:53h | UTC

Reproductive outcomes in women and men conceived by assisted reproductive technologies in Norway: prospective registry based study – BMJ Medicine

News Release: Little evidence that IVF conception heightens future pregnancy risks – BMJ Newsroom

 


Cohort Study | Association between motor vehicle crashes and adverse maternal outcomes in pregnancy

24 Mar, 2023 | 12:54h | UTC

Maternal outcomes in association with motor vehicle crashes during pregnancy: a nationwide population-based retrospective study – Injury Prevention (link to abstract – full text may be available here)

News Release: Pregnant women in traffic collisions at heightened risk of birth complications – BMJ Newsroom

 


Cohort Study | Opioid use for pain relief after birth appears to pose no significant risk to breastfed infants

23 Mar, 2023 | 13:08h | UTC

Summary: This large study from Canada found that infants born to mothers prescribed opioids after delivery, mainly following a cesarean, are at no greater risk of harm shortly after birth than infants of mothers not prescribed opioids. This suggests that breastfeeding is likely safe for babies whose mothers are taking opioids for pain relief.

The study included 865,691 mother-infant pairs discharged from Ontario hospitals within seven days of delivery between September 2012 and March 2020. Researchers matched mothers who filled an opioid prescription within seven days of discharge to those who did not.

Among the infants admitted to the hospital within 30 days, 2,962 (3.5%) were born to mothers who filled an opioid prescription compared with 3,038 (3.5%) born to mothers who did not, showing that infants of mothers prescribed opioids were no more likely to be admitted to the hospital for any reason. These children were only marginally more likely to visit the emergency department in the subsequent 30 days, and no differences were found for other serious outcomes, including breathing problems or admission to a neonatal intensive care unit, and no infant deaths occurred.

Although the study has some limitations, the high initial breastfeeding rates in Canada (90%) and the consistency of the findings with the fact that millions of new mothers are prescribed opioids after delivery each year provide confidence in the conclusions.

Article: Maternal opioid treatment after delivery and risk of adverse infant outcomes: population based cohort study – The BMJ

Editorial: Opioid analgesia for breastfeeding mothers – The BMJ

News Release: Infants of mothers given opioids after birth are at low risk of harm – BMJ Newsroom

 


RCT | Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause

23 Mar, 2023 | 13:01h | UTC

Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study – The Lancet (link to abstract – $ for full-text)

Related: Efficacy and Safety of Fezolinetant in Moderate-to-Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT – The Journal of Clinical Endocrinology & Metabolism

 

Commentary on Twitter (thread – click for more)

 


Cohort Study | Infertility in women linked to increased risk of cardiovascular disease

23 Mar, 2023 | 12:39h | UTC

Infertility and Risk of Cardiovascular Disease: A Prospective Cohort Study – Journal of the American Heart Association

 

Commentary on Twitter

 


Review | The evolution of the labor curve and its implications for clinical practice

22 Mar, 2023 | 13:25h | UTC

The evolution of the labor curve and its implications for clinical practice: the relationship between cervical dilation, station, and time during labor – American Journal of Obstetrics & Gynecology (free for a limited period)

 

Commentary on Twitter

 


M-A | Maternal and neonatal complications following Kielland’s rotational forceps delivery

22 Mar, 2023 | 13:17h | UTC

Maternal and neonatal complications following Kielland’s rotational forceps delivery: A systematic review and meta-analysis – BJOG

 


Comparative study highlights women’s lower susceptibility to sudden cardiac arrest during sports

21 Mar, 2023 | 13:44h | UTC

Summary: This study assessed the incidence, characteristics, and outcomes of sports-related sudden cardiac arrest (Sr-SCA) in women. Data from three European registries were analyzed, identifying 34,826 SCA cases between 2006 and 2017, with 760 cases (2.2%) being Sr-SCA, including 54 in women.

The average annual incidence of Sr-SCA in women was 0.19 per million, over 10 times lower than in men (2.63 per million). When extrapolated to the European population, this translates to 98 cases per year in women and 1,350 cases in men.

Characteristics, bystander response, time to defibrillation, and survival rates did not significantly differ between women and men. The findings highlight the considerably lower risk of Sr-SCA in women compared to men and should be considered when designing preparticipation screening strategies in the future.

Article: Incidence of Cardiac Arrest During Sports Among Women in the European Union – Journal of the American College of Cardiology (link to abstract – $ for full-text)

Commentary: Incidence of Cardiac Arrest During Sports Among Women – American College of Cardiology

 

Commentary on Twitter

 


Review | The sonopartogram

21 Mar, 2023 | 13:12h | UTC

The sonopartogram – American Journal of Obstetrics & Gynecology

 


Review | The latent phase of labor

20 Mar, 2023 | 13:28h | UTC

The latent phase of labor – American Journal of Obstetrics & Gynecology

 

Commentary on Twitter

 


Cohort Study | Leukotriene-receptor antagonist use during pregnancy not linked to neuropsychiatric events in offspring

17 Mar, 2023 | 12:56h | UTC

Use of Leukotriene-Receptor Antagonists During Pregnancy and Risk of Neuropsychiatric Events in Offspring – JAMA Network Open

Commentary: In utero exposure to asthma medication not tied to risks of neurodevelopmental disorders – MDedge

 


SR | Planned hospital birth compared with planned home birth for pregnant women at low risk of complications

17 Mar, 2023 | 12:51h | UTC

Planned hospital birth compared with planned home birth for pregnant women at low risk of complications – Cochrane Library

Summary: Planned hospital birth versus planned home birth – Cochrane Library

 


M-A | Prevalence of perinatal depression in low- and middle-income countries

17 Mar, 2023 | 12:49h | UTC

Prevalence of Perinatal Depression in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis – JAMA Psychiatry

 

Commentary on Twitter

 


Cohort Study | Timing of antidepressant discontinuation during pregnancy and postpartum psychiatric outcomes

17 Mar, 2023 | 12:48h | UTC

Timing of Antidepressant Discontinuation During Pregnancy and Postpartum Psychiatric Outcomes in Denmark and Norway – JAMA Psychiatry

 

Commentary on Twitter

 


Study shows increased nuchal translucency can be ascertained using transverse planes

17 Mar, 2023 | 12:45h | UTC

Increased nuchal translucency can be ascertained using transverse planes – American Journal of Obstetrics & Gynecology

Commentary: Transverse Views In Ultrasound Advantageous To Identify Increased Nuchal Translucency: AJOG – Medical Dialogues

 

Commentary on Twitter

 


FDA issues new information on cases of squamous cell carcinoma and lymphomas around breast implants

16 Mar, 2023 | 13:28h | UTC

Summary: The US Food and Drug Administration (FDA) has provided an update on reports of squamous cell carcinoma (SCC) in the scar tissue (capsule) that forms around breast implants. The FDA is aware of 19 cases of SCC in the capsule around the breast implant from published literature, including 3 reports of deaths from the disease.

While the FDA continues to believe that occurrences of SCC in the capsule around the breast implant may be rare, the cause, incidence, and risk factors remain unknown. Health care providers and people who have or are considering breast implants should be aware that cases of SCC and various lymphomas in the capsule around the breast implant have been reported to the FDA and in the literature.

The FDA continues to ask health care providers and people with breast implants to report cases of SCC, lymphomas, or any other cancers around breast implants.

FDA Safety Communication: Reports of Squamous Cell Carcinoma (SCC) in the Capsule Around Breast Implants – FDA Safety Communication – U.S. Food & Drug Administration

Commentary: FDA Issues Safety Communication on Reports of Squamous Cell Carcinoma in the Capsule Around Breast Implants – The ASCO Post

Related:

FDA Report: 660 Cases of Breast Implant-Associated Anaplastic Large Cell Lymphoma

Study: Long-term Outcomes of Silicone Breast Implants

 


AACC Guidance document on cervical cancer detection: screening, surveillance, and diagnosis

16 Mar, 2023 | 13:21h | UTC

AACC Guidance Document on Cervical Cancer Detection: Screening, Surveillance, and Diagnosis – The Journal of Applied Laboratory Medicine

 


M-A | Maternal and infant outcomes of pregnancy associated with anti-SSA/RO antibodies

16 Mar, 2023 | 13:15h | UTC

Maternal and infant outcomes of pregnancy associated with anti-SSA/RO antibodies: a systematic review and meta-analysis – Pediatric Rheumatology

 


Circulating microparticle proteins predict pregnancies complicated by placenta accreta spectrum

16 Mar, 2023 | 13:05h | UTC

Circulating microparticle proteins predict pregnancies complicated by placenta accreta spectrum – Scientific Reports

News Release: Researchers Identify blood panel to predict placenta accreta – Brigham and Women’s Hospital

 


RCT | Insulin degludec is noninferior to insulin detemir for the treatment of pregnant women with type 1 diabetes

16 Mar, 2023 | 12:59h | UTC

Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open‑label, multinational, randomised, controlled, non-inferiority trial – The Lancet Diabetes & Endocrinology (link to abstract – $ for full-text)

 


Cohort Study | Risk of interpersonal violence during and after pregnancy among people with schizophrenia

16 Mar, 2023 | 12:56h | UTC

Risk of interpersonal violence during and after pregnancy among people with schizophrenia: a population-based cohort study – Canadian Medical Association Journal

News Release: Pregnant people with schizophrenia have threefold risk of interpersonal violence – Canadian Medical Association Journal

 


Updated recommendations for the use of antiretroviral drugs during pregnancy and interventions to reduce perinatal HIV transmission

15 Mar, 2023 | 15:22h | UTC

Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States – Department of Health and Human Services

Commentary: Antiretroviral Therapy During Pregnancy and Interventions to Reduce Perinatal Transmission: 2023 Recommendations – Journal Watch

 


Review | Diagnosis and management of endometriosis

15 Mar, 2023 | 15:19h | UTC

Diagnosis and management of endometriosis – Canadian Medical Association Journal

 


M-A | Risk of recurrence and reintervention after uterine-sparing interventions for symptomatic adenomyosis

15 Mar, 2023 | 15:05h | UTC

Risk of Recurrence and Reintervention After Uterine-Sparing Interventions for Symptomatic Adenomyosis: A Systematic Review and Meta-Analysis – Obstetrics & Gynecology

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.